Prognostic Value of Histological and Immunohistochemical Characteristics for Predicting the Recurrence of Medullary Thyroid Carcinoma
- 12 March 2010
- journal article
- Published by Springer Science and Business Media LLC in Annals of Surgical Oncology
- Vol. 17 (9), 2444-2451
- https://doi.org/10.1245/s10434-010-1021-4
Abstract
Introduction In medullary thyroid carcinoma, there is currently no consensus about the prognostic value of histological and immunohistochemical parameters. This study was designed to analyze the value of various histological and immunohistochemical characteristics for predicting the recurrence of medullary carcinoma. Methods A total of 55 cases of medullary thyroid carcinoma have been reviewed. These were operated on consecutively between 1971 and 2004 after histological confirmation. The data referring to clinical characteristics and evolution were taken from the patient’s clinical history. The macroscopic, microscopic, and immunohistochemical characteristics of the tumors were taken from the pathological anatomy report. Results In 14 (27%) cases, there was recurrence of the disease. The disease-free interval at 1 year was 88 ± 5%; at 5 years 73 ± 7%; at 10 years 73 ± 7%; at 15 years 61 ± 10%; and at 20 years or more 61 ± 10%. Of the histological parameters, only vascular invasion (0.0098) was related to a higher relapse rate. No epidemiological variable or immunohistochemical marker was associated with relapse. However, it was found that staging (P = 0.0102), as well as tumor size (P = 0.0211) and lymph node affectation (P = 0.0012), are factors significantly related to relapse of the disease. According to Cox’s regression model, the only variable with a statistically significant effect was vascular invasion (P = 0.0056; odds ratio = 5.2308). Conclusions The overall recurrence rate was 27%, and the main independent prognostic factor of recurrence was tumoral vascular invasion at diagnosis. Staging, tumor size, and lymph node metastasis are prognostic factors of recurrence, although they are not significant in the multivariate analysis.Keywords
This publication has 39 references indexed in Scilit:
- Medullary Thyroid Cancer: Monitoring and TherapyEndocrinology and Metabolism Clinics of North America, 2007
- Prognosis of medullary thyroid carcinomaCancer, 2006
- Thyroid carcinomaCurrent Opinion in Oncology, 2006
- Expression of cdc25B and cdc25A in medullary thyroid carcinoma: cdc25B expression level predicts a poor prognosisCancer Letters, 2005
- Prognostic Variables and Calcitonin in Medullary Thyroid CancerThe Laryngoscope, 2005
- Medullary thyroid cancer: The controversy continuesCurrent Surgery, 2004
- Risk factors for malignancy in multinodular goitresEuropean Journal of Surgical Oncology, 2004
- Ki-67 Positive Fractions in Benign and Malignant Thyroid Tumours: Application of Flow CytometryActa Oto-Laryngologica, 1999
- Medullary carcinoma of the thyroid in the multiple endocrine neoplasia IIA syndromeThe American Journal of Surgical Pathology, 1981
- Pathological and clinical findings in a series of 67 cases of medullary carcinoma of the thyroidJournal of Clinical Pathology, 1966